Mild to moderate clinical course of COVID-19 infection in patients with common variable immune deficiency.

Lesichkova, Spaska; Mihailova, Snezhina; Naumova, Elisaveta; Yankova, Petya; Krasteva, Yana; Marinova, Ralitsa

Lesichkova, Spaska; Mihailova, Snezhina; Naumova, Elisaveta; Yankova, Petya; Krasteva, Yana; Marinova, Ralitsa.

Afiliación

Lesichkova S; Clinic of Clinical Immunology and Stem Cell Bank, University Hospital Alexandrovska, Sofia, Bulgaria.
Mihailova S; Expert Center for Rare Diseases-PID, University Hospital Alexandrovska, Sofia, Bulgaria.
Naumova E; Department of Clinical Immunology, Medical Faculty, Medical University, Sofia, Bulgaria.
Yankova P; Clinic of Clinical Immunology and Stem Cell Bank, University Hospital Alexandrovska, Sofia, Bulgaria.
Krasteva Y; Expert Center for Rare Diseases-PID, University Hospital Alexandrovska, Sofia, Bulgaria.
Marinova R; Department of Clinical Immunology, Medical Faculty, Medical University, Sofia, Bulgaria.

Cent Eur J Immunol ; 47(4): 357-361, 2022.

Article en En | MEDLINE | ID: mdl-36817399

Palabras clave

COVID-19 infection; T cell immune response; common variable immune deficiency

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Cent Eur J Immunol Año: 2022 Tipo del documento: Article País de afiliación: Bulgaria Pais de publicación: Polonia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google